Your browser doesn't support javascript.
loading
A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [18F]FDG PET/CT.
Zhang, Xiaohui; Chen, Lin; Jiang, Han; He, Xuexin; Feng, Liu; Ni, Miaoqi; Ma, Mindi; Wang, Jing; Zhang, Teng; Wu, Shuang; Zhou, Rui; Jin, Chentao; Zhang, Kai; Qian, Wenbin; Chen, Zexin; Zhuo, Cheng; Zhang, Hong; Tian, Mei.
Afiliación
  • Zhang X; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
  • Chen L; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.
  • Jiang H; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
  • He X; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
  • Feng L; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.
  • Ni M; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
  • Ma M; PET-CT Center, Fujian Medical University Union Hospital, Fuzhou, China.
  • Wang J; Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Zhang T; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
  • Wu S; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.
  • Zhou R; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
  • Jin C; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
  • Zhang K; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.
  • Qian W; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
  • Chen Z; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
  • Zhuo C; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.
  • Zhang H; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
  • Tian M; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
Eur J Nucl Med Mol Imaging ; 49(4): 1298-1310, 2022 03.
Article en En | MEDLINE | ID: mdl-34651227

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Fluorodesoxiglucosa F18 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Fluorodesoxiglucosa F18 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2022 Tipo del documento: Article País de afiliación: China